Loading…

Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus

Aims/Introduction Thrombospondin‐1 (TSP‐1) participates in a series of physiological and pathological processes by binding to various receptors regulating cell proliferation, adhesion and apoptosis. Elevated circulating TSP‐1 is linked with diabetic vascular complications (DVC). This study aimed to...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes investigation 2024-02, Vol.15 (2), p.197-207
Main Authors: Guo, Na, Yang, Linlin, Wan, Xiaozheng, Qiu, Dongze, Sun, Wenwen, Ma, Huijuan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103
cites cdi_FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103
container_end_page 207
container_issue 2
container_start_page 197
container_title Journal of diabetes investigation
container_volume 15
creator Guo, Na
Yang, Linlin
Wan, Xiaozheng
Qiu, Dongze
Sun, Wenwen
Ma, Huijuan
description Aims/Introduction Thrombospondin‐1 (TSP‐1) participates in a series of physiological and pathological processes by binding to various receptors regulating cell proliferation, adhesion and apoptosis. Elevated circulating TSP‐1 is linked with diabetic vascular complications (DVC). This study aimed to determine the relationship between circulating TSP‐1 levels and DVC. Materials and Methods A comprehensive search of PubMed, Embase, Web of Science and CNKI databases was carried out. A meta‐analysis was carried out to compare circulating TSP‐1 levels between diabetes patients without vascular complications (DNVC), diabetes patients with DVC and non‐diabetes patients. The correlation between TSP‐1 and metabolic parameters was also analyzed. Subgroup analysis was carried out according to complication type, defined as diabetic retinopathy, diabetic nephropathy and diabetic cardiovascular disease (DCVD). Results A total of eight studies were included. Compared with non‐diabetes patients, diabetic patients, including DNVC and DVC, had significantly higher circulating TSP‐1 levels (standardized mean difference [SMD] 2.660, 95% CI 1.17–4.145, P = 0.000). DNVC had significantly higher circulating TSP‐1 levels than non‐diabetes patients (SMD 3.613, 95% CI 1.607–5.619, P = 0.000). DVC had significantly higher TSP‐1 levels than DNVC (SMD 0.568, 95% CI 0.100–1.036, P = 0.017). TSP‐1 was significantly positively correlated with fasting plasma glucose (overall Fisher's z = 0.696, 95% CI 0.559–0.833) and HbA1c (overall Fisher's z = 0.849, 95% CI 0.776–0.923). Conclusions Elevated circulating TSP‐1 levels are closely related to DVC, especially in diabetic nephropathy and diabetic cardiovascular disease. Circulating TSP‐1 detection might be helpful in the timely diagnosis and treatment of DVC. This article studied the relationship between circulating thrombospondin‐1 levels and diabetic vascular complications by means of meta‐analysis to provide a target for the diagnosis and treatment of diabetic vascular complications
doi_str_mv 10.1111/jdi.14095
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ea673f5d29694704afed446192d0f469</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ea673f5d29694704afed446192d0f469</doaj_id><sourcerecordid>2876637445</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103</originalsourceid><addsrcrecordid>eNp1kt9qFDEUhwdRbKm98AUk4I1ebJtkMvlzJdJaXSkIotchk5zZzTKTrMnMlt75CD5jn8Rspy5W8NwkJF--HA6_qnpJ8Bkpdb5x_owwrJon1THFDC8IoezpYU_4UXWa8waXqqXkXDyvjmohKSVSHFf5K_Rm9DHktd-iFsYbgICgh50ZwSHrk532QFihcZ3i0Ma8jcH5cPfzF0EFgz4jExzambwnE7Jx2PbezlLkA3LeFC9kNEDf-3HKL6pnnekznD6sJ9X3qw_fLj4trr98XF68v17YhuBm0TLR0Lq1rWOKG2hVJ6yzjLZWEQutJa5rrag5Nrwx4Ky0XDaOSmkZkzXB9Um1nL0umo3eJj-YdKuj8fr-IKaVNmn0tgcNhou6K68VV0xgZjpwjHGiqMMd46q43s2u7dQO5TMIYzL9I-njm-DXehV3mmCJmcK8GN48GFL8MUEe9eCzLSMxAeKUNZWC81ow1hT09T_oJk4plFlpqohoiJRkT72dKZtizgm6QzcE6300dImGvo9GYV_93f6B_BOEApzPwI3v4fb_Jv35cjkrfwNBlcaL</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2917518815</pqid></control><display><type>article</type><title>Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Guo, Na ; Yang, Linlin ; Wan, Xiaozheng ; Qiu, Dongze ; Sun, Wenwen ; Ma, Huijuan</creator><creatorcontrib>Guo, Na ; Yang, Linlin ; Wan, Xiaozheng ; Qiu, Dongze ; Sun, Wenwen ; Ma, Huijuan</creatorcontrib><description>Aims/Introduction Thrombospondin‐1 (TSP‐1) participates in a series of physiological and pathological processes by binding to various receptors regulating cell proliferation, adhesion and apoptosis. Elevated circulating TSP‐1 is linked with diabetic vascular complications (DVC). This study aimed to determine the relationship between circulating TSP‐1 levels and DVC. Materials and Methods A comprehensive search of PubMed, Embase, Web of Science and CNKI databases was carried out. A meta‐analysis was carried out to compare circulating TSP‐1 levels between diabetes patients without vascular complications (DNVC), diabetes patients with DVC and non‐diabetes patients. The correlation between TSP‐1 and metabolic parameters was also analyzed. Subgroup analysis was carried out according to complication type, defined as diabetic retinopathy, diabetic nephropathy and diabetic cardiovascular disease (DCVD). Results A total of eight studies were included. Compared with non‐diabetes patients, diabetic patients, including DNVC and DVC, had significantly higher circulating TSP‐1 levels (standardized mean difference [SMD] 2.660, 95% CI 1.17–4.145, P = 0.000). DNVC had significantly higher circulating TSP‐1 levels than non‐diabetes patients (SMD 3.613, 95% CI 1.607–5.619, P = 0.000). DVC had significantly higher TSP‐1 levels than DNVC (SMD 0.568, 95% CI 0.100–1.036, P = 0.017). TSP‐1 was significantly positively correlated with fasting plasma glucose (overall Fisher's z = 0.696, 95% CI 0.559–0.833) and HbA1c (overall Fisher's z = 0.849, 95% CI 0.776–0.923). Conclusions Elevated circulating TSP‐1 levels are closely related to DVC, especially in diabetic nephropathy and diabetic cardiovascular disease. Circulating TSP‐1 detection might be helpful in the timely diagnosis and treatment of DVC. This article studied the relationship between circulating thrombospondin‐1 levels and diabetic vascular complications by means of meta‐analysis to provide a target for the diagnosis and treatment of diabetic vascular complications</description><identifier>ISSN: 2040-1116</identifier><identifier>ISSN: 2040-1124</identifier><identifier>EISSN: 2040-1124</identifier><identifier>DOI: 10.1111/jdi.14095</identifier><identifier>PMID: 37822187</identifier><language>eng</language><publisher>Japan: John Wiley &amp; Sons, Inc</publisher><subject>Apoptosis ; Bias ; Cardiovascular disease ; Cardiovascular diseases ; Case reports ; Cell proliferation ; Confidence intervals ; Diabetes ; Diabetes complications ; Diabetes mellitus ; Diabetic nephropathy ; Diabetic retinopathy ; Extracellular matrix ; Glucose ; Kidneys ; Meta-analysis ; Metabolism ; Nephropathy ; Original ; Retinopathy ; Sensitivity analysis ; Statistical analysis ; Thrombospondin ; Thrombospondin‐1</subject><ispartof>Journal of diabetes investigation, 2024-02, Vol.15 (2), p.197-207</ispartof><rights>2023 The Authors. published by Asian Association for the Study of Diabetes (AASD) and John Wiley &amp; Sons Australia, Ltd.</rights><rights>2023 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley &amp; Sons Australia, Ltd.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103</citedby><cites>FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103</cites><orcidid>0000-0002-4176-5013 ; 0009-0005-3214-8995</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2917518815/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2917518815?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11560,25751,27922,27923,37010,37011,44588,46050,46474,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37822187$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guo, Na</creatorcontrib><creatorcontrib>Yang, Linlin</creatorcontrib><creatorcontrib>Wan, Xiaozheng</creatorcontrib><creatorcontrib>Qiu, Dongze</creatorcontrib><creatorcontrib>Sun, Wenwen</creatorcontrib><creatorcontrib>Ma, Huijuan</creatorcontrib><title>Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus</title><title>Journal of diabetes investigation</title><addtitle>J Diabetes Investig</addtitle><description>Aims/Introduction Thrombospondin‐1 (TSP‐1) participates in a series of physiological and pathological processes by binding to various receptors regulating cell proliferation, adhesion and apoptosis. Elevated circulating TSP‐1 is linked with diabetic vascular complications (DVC). This study aimed to determine the relationship between circulating TSP‐1 levels and DVC. Materials and Methods A comprehensive search of PubMed, Embase, Web of Science and CNKI databases was carried out. A meta‐analysis was carried out to compare circulating TSP‐1 levels between diabetes patients without vascular complications (DNVC), diabetes patients with DVC and non‐diabetes patients. The correlation between TSP‐1 and metabolic parameters was also analyzed. Subgroup analysis was carried out according to complication type, defined as diabetic retinopathy, diabetic nephropathy and diabetic cardiovascular disease (DCVD). Results A total of eight studies were included. Compared with non‐diabetes patients, diabetic patients, including DNVC and DVC, had significantly higher circulating TSP‐1 levels (standardized mean difference [SMD] 2.660, 95% CI 1.17–4.145, P = 0.000). DNVC had significantly higher circulating TSP‐1 levels than non‐diabetes patients (SMD 3.613, 95% CI 1.607–5.619, P = 0.000). DVC had significantly higher TSP‐1 levels than DNVC (SMD 0.568, 95% CI 0.100–1.036, P = 0.017). TSP‐1 was significantly positively correlated with fasting plasma glucose (overall Fisher's z = 0.696, 95% CI 0.559–0.833) and HbA1c (overall Fisher's z = 0.849, 95% CI 0.776–0.923). Conclusions Elevated circulating TSP‐1 levels are closely related to DVC, especially in diabetic nephropathy and diabetic cardiovascular disease. Circulating TSP‐1 detection might be helpful in the timely diagnosis and treatment of DVC. This article studied the relationship between circulating thrombospondin‐1 levels and diabetic vascular complications by means of meta‐analysis to provide a target for the diagnosis and treatment of diabetic vascular complications</description><subject>Apoptosis</subject><subject>Bias</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Case reports</subject><subject>Cell proliferation</subject><subject>Confidence intervals</subject><subject>Diabetes</subject><subject>Diabetes complications</subject><subject>Diabetes mellitus</subject><subject>Diabetic nephropathy</subject><subject>Diabetic retinopathy</subject><subject>Extracellular matrix</subject><subject>Glucose</subject><subject>Kidneys</subject><subject>Meta-analysis</subject><subject>Metabolism</subject><subject>Nephropathy</subject><subject>Original</subject><subject>Retinopathy</subject><subject>Sensitivity analysis</subject><subject>Statistical analysis</subject><subject>Thrombospondin</subject><subject>Thrombospondin‐1</subject><issn>2040-1116</issn><issn>2040-1124</issn><issn>2040-1124</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kt9qFDEUhwdRbKm98AUk4I1ebJtkMvlzJdJaXSkIotchk5zZzTKTrMnMlt75CD5jn8Rspy5W8NwkJF--HA6_qnpJ8Bkpdb5x_owwrJon1THFDC8IoezpYU_4UXWa8waXqqXkXDyvjmohKSVSHFf5K_Rm9DHktd-iFsYbgICgh50ZwSHrk532QFihcZ3i0Ma8jcH5cPfzF0EFgz4jExzambwnE7Jx2PbezlLkA3LeFC9kNEDf-3HKL6pnnekznD6sJ9X3qw_fLj4trr98XF68v17YhuBm0TLR0Lq1rWOKG2hVJ6yzjLZWEQutJa5rrag5Nrwx4Ky0XDaOSmkZkzXB9Um1nL0umo3eJj-YdKuj8fr-IKaVNmn0tgcNhou6K68VV0xgZjpwjHGiqMMd46q43s2u7dQO5TMIYzL9I-njm-DXehV3mmCJmcK8GN48GFL8MUEe9eCzLSMxAeKUNZWC81ow1hT09T_oJk4plFlpqohoiJRkT72dKZtizgm6QzcE6300dImGvo9GYV_93f6B_BOEApzPwI3v4fb_Jv35cjkrfwNBlcaL</recordid><startdate>202402</startdate><enddate>202402</enddate><creator>Guo, Na</creator><creator>Yang, Linlin</creator><creator>Wan, Xiaozheng</creator><creator>Qiu, Dongze</creator><creator>Sun, Wenwen</creator><creator>Ma, Huijuan</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4176-5013</orcidid><orcidid>https://orcid.org/0009-0005-3214-8995</orcidid></search><sort><creationdate>202402</creationdate><title>Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus</title><author>Guo, Na ; Yang, Linlin ; Wan, Xiaozheng ; Qiu, Dongze ; Sun, Wenwen ; Ma, Huijuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Apoptosis</topic><topic>Bias</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Case reports</topic><topic>Cell proliferation</topic><topic>Confidence intervals</topic><topic>Diabetes</topic><topic>Diabetes complications</topic><topic>Diabetes mellitus</topic><topic>Diabetic nephropathy</topic><topic>Diabetic retinopathy</topic><topic>Extracellular matrix</topic><topic>Glucose</topic><topic>Kidneys</topic><topic>Meta-analysis</topic><topic>Metabolism</topic><topic>Nephropathy</topic><topic>Original</topic><topic>Retinopathy</topic><topic>Sensitivity analysis</topic><topic>Statistical analysis</topic><topic>Thrombospondin</topic><topic>Thrombospondin‐1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guo, Na</creatorcontrib><creatorcontrib>Yang, Linlin</creatorcontrib><creatorcontrib>Wan, Xiaozheng</creatorcontrib><creatorcontrib>Qiu, Dongze</creatorcontrib><creatorcontrib>Sun, Wenwen</creatorcontrib><creatorcontrib>Ma, Huijuan</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley-Blackwell Open Access Backfiles (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of diabetes investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guo, Na</au><au>Yang, Linlin</au><au>Wan, Xiaozheng</au><au>Qiu, Dongze</au><au>Sun, Wenwen</au><au>Ma, Huijuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus</atitle><jtitle>Journal of diabetes investigation</jtitle><addtitle>J Diabetes Investig</addtitle><date>2024-02</date><risdate>2024</risdate><volume>15</volume><issue>2</issue><spage>197</spage><epage>207</epage><pages>197-207</pages><issn>2040-1116</issn><issn>2040-1124</issn><eissn>2040-1124</eissn><abstract>Aims/Introduction Thrombospondin‐1 (TSP‐1) participates in a series of physiological and pathological processes by binding to various receptors regulating cell proliferation, adhesion and apoptosis. Elevated circulating TSP‐1 is linked with diabetic vascular complications (DVC). This study aimed to determine the relationship between circulating TSP‐1 levels and DVC. Materials and Methods A comprehensive search of PubMed, Embase, Web of Science and CNKI databases was carried out. A meta‐analysis was carried out to compare circulating TSP‐1 levels between diabetes patients without vascular complications (DNVC), diabetes patients with DVC and non‐diabetes patients. The correlation between TSP‐1 and metabolic parameters was also analyzed. Subgroup analysis was carried out according to complication type, defined as diabetic retinopathy, diabetic nephropathy and diabetic cardiovascular disease (DCVD). Results A total of eight studies were included. Compared with non‐diabetes patients, diabetic patients, including DNVC and DVC, had significantly higher circulating TSP‐1 levels (standardized mean difference [SMD] 2.660, 95% CI 1.17–4.145, P = 0.000). DNVC had significantly higher circulating TSP‐1 levels than non‐diabetes patients (SMD 3.613, 95% CI 1.607–5.619, P = 0.000). DVC had significantly higher TSP‐1 levels than DNVC (SMD 0.568, 95% CI 0.100–1.036, P = 0.017). TSP‐1 was significantly positively correlated with fasting plasma glucose (overall Fisher's z = 0.696, 95% CI 0.559–0.833) and HbA1c (overall Fisher's z = 0.849, 95% CI 0.776–0.923). Conclusions Elevated circulating TSP‐1 levels are closely related to DVC, especially in diabetic nephropathy and diabetic cardiovascular disease. Circulating TSP‐1 detection might be helpful in the timely diagnosis and treatment of DVC. This article studied the relationship between circulating thrombospondin‐1 levels and diabetic vascular complications by means of meta‐analysis to provide a target for the diagnosis and treatment of diabetic vascular complications</abstract><cop>Japan</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>37822187</pmid><doi>10.1111/jdi.14095</doi><tpages>207</tpages><orcidid>https://orcid.org/0000-0002-4176-5013</orcidid><orcidid>https://orcid.org/0009-0005-3214-8995</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2040-1116
ispartof Journal of diabetes investigation, 2024-02, Vol.15 (2), p.197-207
issn 2040-1116
2040-1124
2040-1124
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ea673f5d29694704afed446192d0f469
source Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content (ProQuest); PubMed Central
subjects Apoptosis
Bias
Cardiovascular disease
Cardiovascular diseases
Case reports
Cell proliferation
Confidence intervals
Diabetes
Diabetes complications
Diabetes mellitus
Diabetic nephropathy
Diabetic retinopathy
Extracellular matrix
Glucose
Kidneys
Meta-analysis
Metabolism
Nephropathy
Original
Retinopathy
Sensitivity analysis
Statistical analysis
Thrombospondin
Thrombospondin‐1
title Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A48%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20between%20elevated%20circulating%20thrombospondin%E2%80%901%20levels%20and%20vascular%20complications%20in%20diabetes%20mellitus&rft.jtitle=Journal%20of%20diabetes%20investigation&rft.au=Guo,%20Na&rft.date=2024-02&rft.volume=15&rft.issue=2&rft.spage=197&rft.epage=207&rft.pages=197-207&rft.issn=2040-1116&rft.eissn=2040-1124&rft_id=info:doi/10.1111/jdi.14095&rft_dat=%3Cproquest_doaj_%3E2876637445%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5105-b47523bcbd496aeb9f7cdc42bc91cebc1dfbc7360a65aedc8c685d288c4483103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2917518815&rft_id=info:pmid/37822187&rfr_iscdi=true